학술논문
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial
Document Type
Article
Author
de Gooijer, Cornedine J; van der Noort, Vincent; Stigt, Jos A; Baas, Paul; Biesma, Bonne; Cornelissen, Robin; van Walree, Nico; van Heemst, Robbert C; Soud, Magdolen Youssef-El; Groen, Harry J M; den Brekel, Agnes J Staal-van; Buikhuisen, Wieneke A; Bootsma, Gerben P; Dammeijer, Floris; van Tinteren, Harm; Lalezari, Ferry; Aerts, Joachim G; Burgers, Jacobus A
Source
In The Lancet Respiratory Medicine June 2021 9(6):585-592
Subject
Language
ISSN
2213-2600